Literature DB >> 17967869

Shuttling imbalance of MLF1 results in p53 instability and increases susceptibility to oncogenic transformation.

Noriko Yoneda-Kato1, Jun-Ya Kato.   

Abstract

Myeloid leukemia factor 1 (MLF1) stabilizes the activity of the tumor suppressor p53 by suppressing its E3 ubiquitin ligase, COP1, through a third component of the COP9 signalosome (CSN3). However, little is known about how MLF1 functions upstream of the CSN3-COP1-p53 pathway and how its deregulation by the formation of the fusion protein nucleophosmin (NPM)-MLF1, generated by t(3;5)(q25.1;q34) chromosomal translocation, leads to leukemogenesis. Here we show that MLF1 is a cytoplasmic-nuclear-shuttling protein and that its nucleolar localization on fusing with NPM prevents the full induction of p53 by both genotoxic and oncogenic cellular stress. The majority of MLF1 was located in the cytoplasm, but the treatment of cells with leptomycin B rapidly induced a nuclear accumulation of MLF1. A mutation of the nuclear export signal (NES) motif identified in the MLF1 sequence enhanced the antiproliferative activity of MLF1. The fusion of MLF1 with NPM translocated MLF1 to the nucleolus and abolished the growth-suppressing activity. The introduction of NPM-MLF1 into early-passage murine embryonic fibroblasts allowed the cells to escape from cellular senescence at a markedly earlier stage and induced neoplastic transformation in collaboration with the oncogenic form of Ras. Interestingly, disruption of the MLF1-derived NES sequence completely abolished the growth-promoting activity of NPM-MLF1 in murine fibroblasts and hematopoietic cells. Thus, our results provide important evidence that the shuttling of MLF1 is critical for the regulation of cell proliferation and a disturbance in the shuttling balance increases the cell's susceptibility to oncogenic transformation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17967869      PMCID: PMC2223285          DOI: 10.1128/MCB.02335-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

Review 1.  14-3-3 proteins: structure, function, and regulation.

Authors:  H Fu; R R Subramanian; S C Masters
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

2.  High-efficiency transformation of mammalian cells by plasmid DNA.

Authors:  C Chen; H Okayama
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

3.  Translocation of nucleolar phosphoprotein B23 (37 kDa/pI 5.1) induced by selective inhibitors of ribosome synthesis.

Authors:  B Y Yung; H Busch; P K Chan
Journal:  Biochim Biophys Acta       Date:  1985-12-18

4.  Major nucleolar proteins shuttle between nucleus and cytoplasm.

Authors:  R A Borer; C F Lehner; H M Eppenberger; E A Nigg
Journal:  Cell       Date:  1989-02-10       Impact factor: 41.582

5.  Versatile retroviral vectors for potential use in gene therapy.

Authors:  R G Hawley; F H Lieu; A Z Fong; T S Hawley
Journal:  Gene Ther       Date:  1994-03       Impact factor: 5.250

Review 6.  Trichostatin and leptomycin. Inhibition of histone deacetylation and signal-dependent nuclear export.

Authors:  M Yoshida; S Horinouchi
Journal:  Ann N Y Acad Sci       Date:  1999       Impact factor: 5.691

7.  The t(5;17) acute promyelocytic leukemia fusion protein NPM-RAR interacts with co-repressor and co-activator proteins and exhibits both positive and negative transcriptional properties.

Authors:  R L Redner; J D Chen; E A Rush; H Li; S L Pollock
Journal:  Blood       Date:  2000-04-15       Impact factor: 22.113

8.  The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion.

Authors:  R L Redner; E A Rush; S Faas; W A Rudert; S J Corey
Journal:  Blood       Date:  1996-02-01       Impact factor: 22.113

9.  Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.

Authors:  S W Morris; M N Kirstein; M B Valentine; K G Dittmer; D N Shapiro; D L Saltman; A T Look
Journal:  Science       Date:  1994-03-04       Impact factor: 47.728

10.  The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1.

Authors:  N Yoneda-Kato; A T Look; M N Kirstein; M B Valentine; S C Raimondi; K J Cohen; A J Carroll; S W Morris
Journal:  Oncogene       Date:  1996-01-18       Impact factor: 9.867

View more
  11 in total

Review 1.  In the land of the rising sun with the COP9 signalosome and related Zomes. Symposium on the COP9 signalosome, Proteasome and eIF3.

Authors:  Elah Pick; Lionel Pintard
Journal:  EMBO Rep       Date:  2009-03-13       Impact factor: 8.807

2.  Myeloid leukemia factor 1 stabilizes tumor suppressor C/EBPα to prevent Trib1-driven acute myeloid leukemia.

Authors:  Ikuko Nakamae; Jun-Ya Kato; Takashi Yokoyama; Hidenori Ito; Noriko Yoneda-Kato
Journal:  Blood Adv       Date:  2017-09-01

3.  Estrogen induced breast cancer is the result in the disruption of the asymmetric cell division of the stem cell.

Authors:  Jose Russo; Kara Snider; Julia S Pereira; Irma H Russo
Journal:  Horm Mol Biol Clin Investig       Date:  2010-01-01

4.  Distant homologs of anti-apoptotic factor HAX1 encode parvalbumin-like calcium binding proteins.

Authors:  Katarzyna Kokoszyńska; Leszek Rychlewski; Lucjan S Wyrwicz
Journal:  BMC Res Notes       Date:  2010-07-15

5.  Myeloid leukemia factor: a return ticket from human leukemia to fly hematopoiesis.

Authors:  Vanessa Gobert; Marc Haenlin; Lucas Waltzer
Journal:  Transcription       Date:  2012-09-01

6.  Rare variants in ischemic stroke: an exome pilot study.

Authors:  John W Cole; O Colin Stine; Xinyue Liu; Abhishek Pratap; Yuching Cheng; Luke J Tallon; Lisa K Sadzewicz; Nicole Dueker; Marcella A Wozniak; Barney J Stern; James F Meschia; Braxton D Mitchell; Steven J Kittner; Jeffrey R O'Connell
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

7.  Common variants upstream of MLF1 at 3q25 and within CPZ at 4p16 associated with neuroblastoma.

Authors:  Lee D McDaniel; Karina L Conkrite; Xiao Chang; Mario Capasso; Zalman Vaksman; Derek A Oldridge; Anna Zachariou; Millicent Horn; Maura Diamond; Cuiping Hou; Achille Iolascon; Hakon Hakonarson; Nazneen Rahman; Marcella Devoto; Sharon J Diskin
Journal:  PLoS Genet       Date:  2017-05-18       Impact factor: 5.917

8.  From Benign Inflammatory Dermatosis to Cutaneous Lymphoma. DNA Copy Number Imbalances in Mycosis Fungoides versus Large Plaque Parapsoriasis.

Authors:  Georgiana Gug; Caius Solovan
Journal:  Medicina (Kaunas)       Date:  2021-05-15       Impact factor: 2.430

9.  Transcriptional program of ciliated epithelial cells reveals new cilium and centrosome components and links to human disease.

Authors:  Ramona A Hoh; Timothy R Stowe; Erin Turk; Tim Stearns
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

10.  Sperm and spermatids contain different proteins and bind distinct egg factors.

Authors:  Marta Teperek; Kei Miyamoto; Angela Simeone; Renata Feret; Michael J Deery; John B Gurdon; Jerome Jullien
Journal:  Int J Mol Sci       Date:  2014-09-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.